Institutional investors purchased a net $2.6 million shares of SNTA during the quarter ended March 2015. This may signal that the smart money is gaining interest in this company as the 48.28% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LIFESCI INDEX PARTNERS LLC Bought 41.1 Thousand shares of Synta Pharmaceuticals Cor...